ALLE:NYSEAllegion plc Analysis
Data as of 2026-08-16 - not real-time
$164.78
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind Allegion plc is neutral at $164.78, with no clear ordering between short and long averages. Over a rolling month the price has gained 17.8%. Momentum indicators put RSI at 67.3 (approaching overbought) with MACD reading bullish. Price has been bracketed by support at $134.63 and resistance at $170.87.
The shares look fair, trading on 21.7 times earnings below a sector average of 30.9. Sell-side targets cluster 6.0% above the current quote. Revenue is growing at 12.7% on a 15.4% profit margin. The 1.29% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 36.7%, a beta of 0.56 and a maximum drawdown of 30.1%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 6/10.
The shares look fair, trading on 21.7 times earnings below a sector average of 30.9. Sell-side targets cluster 6.0% above the current quote. Revenue is growing at 12.7% on a 15.4% profit margin. The 1.29% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 36.7%, a beta of 0.56 and a maximum drawdown of 30.1%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 6/10.
Top Market Events
Low-Double Digit Revenue Growth, High-Teens EPS Growth; Raising Full-Year 2026 Outlook Quarterly Financial Highlights...Low-Double Digit Revenue Growth, High-Teens EPS Growth; Raising Full-Year 2026 Outlook Quarterly Financial Highlights...Allegion PLC ALLE reports robust performance in the Americas, raises full-year revenue and EPS outlook, despite...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 5/10
Key Factors
- Trading above the 200-day average of 151.60
- MACD momentum is positive
- 30-day price change of +17.8%
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 21.7 versus sector average of 30.9
- Trading above the 200-day average of 151.60
- Analyst targets imply +6.0% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 21.7 versus sector average of 30.9
- Analyst targets imply +6.0% versus the current price
- Profit margin of 15.4% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth12.70%
Profit Margin15.36%
P/E Ratio21.7
ROE33.73%
ROA11.03%
Debt/Equity104.89
P/B Ratio6.6
Op. Cash Flow$769.3M
Free Cash Flow$484.4M
Industry P/E30.9
Technical Analysis
TrendNeutral
RSI67.3
Support$134.63
Resistance$170.87
MA 20$157.43
MA 50$143.85
MA 200$151.60
MACDBullish
VolumeDecreasing
Fear & Greed Index95.98
Valuation
Fair Value$102.63
Target Price$174.64
Upside/Downside5.98%
GradeFair
TypeBlend
Dividend Yield1.29%
Risk Assessment
Beta0.56
Volatility36.71%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.